Integrating clinical pharmacy activities into the care pathway for pediatric kidney transplant patients (notice n° 191247)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01913cam a2200265 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250112044551.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Martin, Julie |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Integrating clinical pharmacy activities into the care pathway for pediatric kidney transplant patients |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2023.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 45 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | The pediatric kidney transplant pathway is at risk of care discontinuation, despite therapeutic adherence being essential. The aim of this feasibility study is to evaluate the integration of clinical pharmacy activities into this care pathway. The study is divided into three stages: structuring, implementing, and evaluation. In the pre-transplant and immediate and remote post-transplant phases, interviews were conducted, alongside the pharmaceutical analysis of medication prescriptions. Across an 8-month period, 32 patients were included. All patients included in the pre-transplant and immediate post-transplant phases benefited from the activities. At M0, all the prescriptions analyzed resulted in at least one problem being detected. Half of the transplanted patients benefited from M1 maintenance, one patient from M3 maintenance, and no M6 follow-up could be carried out. This study shows that integrating clinical pharmacy activities into the care pathway is highly feasible. |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jandot, Élise |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bréant, Valentine |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sellier-Leclerc |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mouchoux, Christelle |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lattard, Claire |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bacchetta, Justine |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Larger, Magali |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dode, Xavier |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hoegy, Delphine |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Néphrologie & Thérapeutique | Volume 19 | 7 | 2023-07-01 | p. 568-574 | 1769-7255 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/journal-nephrologie-therapeutique-2023-7-page-568?lang=en">https://shs.cairn.info/journal-nephrologie-therapeutique-2023-7-page-568?lang=en</a> |
Pas d'exemplaire disponible.
Réseaux sociaux